Dasashil - Dasatinib 70mg 60 Tablets (Sprycel) - Anticancer Medication

Dasashil (Dasatinib 70mg) x 60 Tablets

$350.00 $132.00
image Prescription Required

Dasashil 70mg is a prescription cancer medicine that contains Dasatinib, a tyrosine kinase inhibitor (TKI), and it is primarily used in the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).

Generic Name Dasatinib
Manufacturer Shilpa Medicare Ltd
Packing 60 Tablets in 1 Bottle
Prescribed For Blood Cancer
Availability In Stock

Contact us on WhatsApp

Genuine Medicines

Quick Air Delivery

Secure Payment

24/7 Support

Benefits of Dasashil 70mg

  • Treats chronic myeloid leukemia (CML)
  • Blocks cancer cell growth
  • Targets specific cancer proteins
  • Supports long-term therapy

Side Effects

  • Nausea, vomiting, and diarrhea
  • Fatigue or weakness
  • Headache
  • Skin rash or itching
  • Muscle or joint pain
  • Swelling in hands, feet, or around the eyes (edema)
  • Loss of appetite

Caution:

  • Take exactly as prescribed.
  • Do not skip or stop doses without medical advice.
  • Inform your doctor of heart, lung, or liver problems.
  • Monitor blood counts and heart function regularly.
  • Avoid grapefruit or grapefruit juice.
  • Not a cure; continue regular check-ups.
  • Do not share medication.

Order Dasashil (Dasatinib 70mg) Tablets in Bulk at Low Prices

As a trusted provider of high-quality generic anticancer medicines, we offer authentic Dasashil (Dasatinib 70mg) Tablets, commonly prescribed for the treatment of Philadelphia chromosome–positive chronic myeloid leukemia (Ph+ CML) and Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL).

We guarantee safe, timely, and consistent bulk supply of oncology drugs, including Dasatinib (Generic Sprycel), to hospitals, clinics, pharmacies, healthcare providers, physicians, NGOs, and authorized buyers in over 80 countries worldwide. Our global distribution network spans Latin America, Africa, Asia, Europe, the Middle East, and North America, covering key markets such as Mexico, Brazil, Colombia, Peru, Chile, UAE, Saudi Arabia, Egypt, South Africa, Namibia, Kenya, Nigeria, Singapore, Vietnam, Thailand, the Philippines, Canada, and many more.

Disclaimer

This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.

Need assistance? Chat with us